Clinical trial
Effect of Atorvastatin (Lipitor) on Gene Expression in People With Vascular…
NCT00293748 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00293748 |
|---|---|
| Title | Effect of Atorvastatin (Lipitor) on Gene Expression in People With Vascular Disease |
| Official title | Dose-Response Study of Modulation of Gene Expression in Peripheral Blood Mononuclear Cells by Atorvastatin |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Vascular Disease, Vascular Disease Risk |
| Enrollment | 200 |
| Start date | Feb 13, 2006 |
| Completion | Dec 15, 2008 |
| First posted | Feb 17, 2006 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: